Table 2 Anticoagulation and anti-aggregation treatment and mortality for the ICH dataset
Under anticoagulation/anti-aggregation | Not under anticoagulation/anti-aggregation | |||
|---|---|---|---|---|
Not deceased | Deceased | Not deceased | Deceased | |
Mortality 30 days | ||||
Pre-AI, N (% of total) | 54 (63.5%) | 31 (36.5%) | 111 (77.6%) | 32 (22.4%) |
Post-AI, N (% of total) | 62 (82.6%) | 13 (17.4%) | 165 (82.5%) | 35 (17.5%) |
% Change | − 52.3% p = 0.01147 | − 21.8% p = 0.3245 | ||
Mortality 120 days | ||||
Pre-AI, N (% of total) | 54 (58.1%) | 39 (41.9%) | 111 (74.5%) | 38 (25.5%) |
Post-AI, N (% of total) | 62 (76.5%) | 19 (23.5%) | 165 (78.9%) | 44 (21.1%) |
% Change | − 43.9% p = 0.01561 | − 17.2% p = 0.3897 | ||